Sotak Tara P, Troxler Heidi B, Kirkley Amber M, Joyner Benny L, Steiner Michael J, Donnelly Lane F
Jt Comm J Qual Patient Saf. 2025 Jul-Aug;51(7-8):493-497. doi: 10.1016/j.jcjq.2025.04.006. Epub 2025 Apr 26.
The aim of this study was to evaluate one institution's five-year experience with the frequency of multiple central line-associated bloodstream infections (CLABSIs) occurring in the same child and to discuss the importance of previous CLABSI as a risk factor for future CLABSI and the implications for CLABSI rate calculation.
The infection surveillance system includes data on central line days, CLABSI rate, and CLABSI count, including mucosal barrier injury (MBI) and non-MBI CLABSIs. Using this data, the authors determined the number of children who had more than one inpatient CLABSI during a five-year period. The team then calculated the percentage of total CLABSIs that are represented by patients with more than one CLABSI and the percentage of patients with CLABSI who had multiple CLABSIs.
During the five-year study period, there were 138 CLABSIs in 119 patients. Of the 138 CLABSIs, 36 (26.1%) occurred in children who had more than one CLABSI and 19 (13.8%) of those were repeat. Seventeen patients had more than 1 inpatient CLABSI (15 patients with 2 CLABSIs, and 2 patients with 3 CLABSIs). The CLABSI rate for this period was 1.83 per 1,000 central line days. With exclusion of repeat CLABSIs, the CLABSI rate would be 1.58 per 1,000 central line days, representing a 13.7% difference.
Repeat CLABSI in the same patient is not uncommon and can contribute significantly to overall inpatient CLABSI rates. Prior CLABSI should be considered a risk factor for future CLABSI.
本研究的目的是评估一家机构在同一儿童中发生多重中心静脉导管相关血流感染(CLABSI)的频率的五年经验,并讨论既往CLABSI作为未来CLABSI危险因素的重要性以及对CLABSI发生率计算的影响。
感染监测系统包括中心静脉导管使用天数、CLABSI发生率和CLABSI计数的数据,包括黏膜屏障损伤(MBI)和非MBI CLABSI。利用这些数据,作者确定了在五年期间发生不止一次住院CLABSI的儿童数量。然后该团队计算了不止一次发生CLABSI的患者所导致的CLABSI总数的百分比以及发生CLABSI的患者中不止一次发生CLABSI的百分比。
在五年研究期间,119名患者发生了138例CLABSI。在这138例CLABSI中,36例(26.1%)发生在不止一次发生CLABSI的儿童中,其中19例(13.8%)为再次感染。17名患者发生不止一次住院CLABSI(15名患者发生2次CLABSI,2名患者发生3次CLABSI)。该期间的CLABSI发生率为每1000中心静脉导管使用日1.83例。排除再次发生的CLABSI后,CLABSI发生率将为每1000中心静脉导管使用日1.58例,相差13.7%。
同一患者再次发生CLABSI并不罕见,且可显著影响总体住院CLABSI发生率。既往CLABSI应被视为未来CLABSI的危险因素。